Publication | Closed Access

Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyCombined RegimenMyeloid NeoplasiaPharmacotherapyMedicineRadiation OncologyClinical OutcomeCancer ResearchHealth Sciences